Results 201 to 210 of about 332,337 (302)
Correction: Measuring novelty in science with word embedding. [PDF]
PLOS One Staff.
europepmc +1 more source
ABSTRACT Background Patients with inflammatory bowel disease (IBD) are often less active physically and experience impaired bone mineral density (BMD) as well as sarcopenia, which are associated with a higher risk of poor disease outcomes. Physical exercise can improve BMD and sarcopenia and may also play a role in controlling inflammation via anti ...
Emese Kasznár +10 more
wiley +1 more source
ERRATUM: Impact of an educational intervention on postpartum depression for primary care nurses: a quasi-experimental study. [PDF]
europepmc +1 more source
Hemorrhoidal elastic band ligation during routine colonoscopy: A comparative study between flexible video endoscopy and rigid proctoscopy. [PDF]
Gomes A +5 more
europepmc +1 more source
Health hazard evaluation report: HETA-91-070-2194, Library of Congress, Washington, D.C.
C. E. Moss +6 more
openalex +1 more source
ABSTRACT Background Skeletal muscle wasting and weakness are prominent disease features. Originally considered to arise from common transcriptional changes, recent analyses demonstrated that different stimuli induce muscle wasting via largely distinct mRNA and protein changes.
Anna Stephan +6 more
wiley +1 more source
Correction: Faculty's lived experiences in recognizing nursing students' psychological support needs in Saudi Arabia. [PDF]
Alqhtani SS, Alselami S, Alnajjar H.
europepmc +1 more source
Identification of the MICA∗070 allele by sequencing and phasing
D. Moran +3 more
openalex +1 more source
ABSTRACT Tumour development and progression are driven by intricate interactions among various cell types within the tumour microenvironment (TME). Targeting a single cell type often fails to eradicate cancer, highlighting the need for strategies to co‐target multiple cell types.
Zhiang Liu +14 more
wiley +1 more source
Prevalence of dry eye disease symptoms and impact on quality-of-life among hospital staff during the COVID-19 pandemic. [PDF]
Tananuvat N +4 more
europepmc +1 more source

